Save

Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study

In: Beneficial Microbes
Authors:
K. Miyazawa Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by K. Miyazawa in
Current site
Google Scholar
PubMed
Close
,
M. Kawase Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by M. Kawase in
Current site
Google Scholar
PubMed
Close
,
A. Kubota Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by A. Kubota in
Current site
Google Scholar
PubMed
Close
,
K. Yoda Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by K. Yoda in
Current site
Google Scholar
PubMed
Close
,
G. Harata Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by G. Harata in
Current site
Google Scholar
PubMed
Close
,
M. Hosoda Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by M. Hosoda in
Current site
Google Scholar
PubMed
Close
, and
F. He Technical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, Kanagawa 241-0023, Japan

Search for other papers by F. He in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

€36.93

This double-blind, placebo-controlled clinical trial was conducted to test whether Lactobacillus gasseri TMC0356 (TMC0356) can modify the immune response in the elderly. Heat-killed TMC0356 or placebo was orally administered to 28 healthy subjects aged 50-70 years old for 4 weeks at a dosage of 1.0×109 cfu/day. Peripheral blood mononuclear cells (PBMCs) were collected from the subjects before and after the study completion, together with general health and blood examination records. Isolated PBMCs were examined for the number of T cells, CD8+CD28+ cells, native T cells, B cells, natural killer (NK) cells and the ratios of CD4/CD8 T cells and native/memory T cells. NK cell activation and concanavalin A-induced lymphocyte transformation of the isolated PBMCs were also examined. The number of CD8+ T cells significantly increased in the subjects after TMC0356 oral administration (P<0.05). Furthermore, the population of CD8+CD28+ T cells and the amount of lymphocyte transformation both significantly decreased in PBMCs from the placebo group (P<0.05). However, such changes were not observed in the subjects exposed to TMC0356. These results suggest that TMC0356 can increase the number of CD8+ T cells and reduce CD28 expression loss in CD8+ T cells of the elderly. The effect of TMC0356 on immune responses in the elderly may enhance their natural defence mechanisms against pathogenic infections.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 969 329 23
Full Text Views 58 14 0
PDF Views & Downloads 47 13 0